Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Denis Ignatov"'
Autor:
Marcel Benkhoff, Bodo Levkau, Aysel Ayhan, Tobias Petzold, Kajetan Trojovsky, Saif Zako, Ragnar Huhn-Wientgen, Philipp Mourikis, Carolin Helten, Lisa Dannenberg, Amin Polzin, Denis Ignatov, René M'Pembele, Tobias Zeus, Theresia Sarabhai, Malte Kelm
Publikováno v:
Pharmacology. 106:225-232
Background: Targeting inflammation in patients with coronary artery disease and/or acute myocardial infarction (AMI) is a matter of debate. Methotrexate (MTX) is one of the most widely used immunosuppressants. Cardiovascular Inflammation Reduction Tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f105a92c0c82bc72ea9e95d8c3a664b2
https://doi.org/10.1159/000511279
https://doi.org/10.1159/000511279
Autor:
Kajetan Trojovsky, Bodo Levkau, Natalia Czychy, Philipp Mourikis, Lisa Dannenberg, Carolin Helten, Manuela Thienel, Lilian Vornholz, Saif Zako, Florian Bönner, Tobias Zeus, Malte Kelm, Tobias Petzold, Daniel Metzen, René M'Pembele, Amin Polzin, Denis Ignatov
Publikováno v:
Diabetic medicine : a journal of the British Diabetic AssociationREFERENCES. 38(5)
Dual platelet inhibition (DAPT) is crucial after percutaneous coronary intervention (PCI), especially for diabetes mellitus (DM) patients. Guidelines recommend 3-12 months of DAPT post PCI (1). However, prolongation up to 30 months is discussed. More
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::940b77537afa8869bb3d3a241faca25a
https://pubmed.ncbi.nlm.nih.gov/33511685
https://pubmed.ncbi.nlm.nih.gov/33511685